PRAK Suppresses Oncogenic ras-Induced Hematopoietic Cancer Development by Antagonizing the JNK Pathway
暂无分享,去创建一个
Ryan Cook | Rong Liao | Peiqing Sun | Jiahuai Han | C. Xiao | Jiahuai Han | Ryan Cook | Rong Liao | P. Sun | Changchun Xiao | Maoyi Lai | Naoto Yoshizuka | M. Lai | N. Yoshizuka | Changchun Xiao | Peiqing Sun
[1] J. Pollack,et al. c-Jun N-terminal kinase is activated in non-small-cell lung cancer and promotes neoplastic transformation in human bronchial epithelial cells , 2007, Oncogene.
[2] J. D. Di Santo,et al. c-Jun NH2-terminal kinase/c-Jun signaling promotes survival and metastasis of B lymphocytes transformed by Theileria. , 2006, Cancer research.
[3] G. Hannon,et al. p53-independent role of MDM2 in TGF-beta1 resistance. , 1998, Science.
[4] M. Barbacid,et al. p38alpha MAP kinase is essential in lung stem and progenitor cell proliferation and differentiation. , 2007, Nature genetics.
[5] M. Barbacid,et al. Tumour biology: Senescence in premalignant tumours , 2005, Nature.
[6] Christian Haslinger,et al. p38α suppresses normal and cancer cell proliferation by antagonizing the JNK–c-Jun pathway , 2007, Nature Genetics.
[7] M. Gaestel,et al. In the Cellular Garden of Forking Paths: How p38 MAPKs Signal for Downstream Assistance , 2002, Biological chemistry.
[8] Jiahuai Han,et al. The p38 signal transduction pathway: activation and function. , 2000, Cellular signalling.
[9] J. Shay,et al. BRAFE600-associated senescence-like cell cycle arrest of human naevi , 2005, Nature.
[10] Jerry L. Adams,et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis , 1994, Nature.
[11] Michel Morange,et al. A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins , 1994, Cell.
[12] R. Flavell,et al. Defective T cell differentiation in the absence of Jnk1. , 1998, Science.
[13] D. Vaux,et al. Transgenic mouse models for hematopoietic tumorigenesis. , 1988, Current topics in microbiology and immunology.
[14] J. Yates,et al. PRAK Is Essential for ras-Induced Senescence and Tumor Suppression , 2007, Cell.
[15] E. Ranheim,et al. Endogenous oncogenic Nras mutation initiates hematopoietic malignancies in a dose- and cell type-dependent manner. , 2011, Blood.
[16] Yong Jiang,et al. PRAK, a novel protein kinase regulated by the p38 MAP kinase , 1998, The EMBO journal.
[17] Jason A. Koutcher,et al. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis , 2005, Nature.
[18] M. Serrano,et al. The power and the promise of oncogene-induced senescence markers , 2006, Nature Reviews Cancer.
[19] S. Lowe,et al. Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a , 1997, Cell.
[20] G. Hannon,et al. p53-Independent Role of MDM2 in TGF-β1 Resistance , 1998 .
[21] J. Shay,et al. Senescence and immortalization: role of telomeres and telomerase. , 2005, Carcinogenesis.
[22] T. Jacks,et al. Hematopoiesis and leukemogenesis in mice expressing oncogenic NrasG12D from the endogenous locus. , 2011, Blood.
[23] P. Ling,et al. Leukocyte-specific adaptor protein Grap2 interacts with hematopoietic progenitor kinase 1 (HPK1) to activate JNK signaling pathway in T lymphocytes , 2001, Oncogene.
[24] E. Wagner,et al. Control of cell cycle progression by c-Jun is p53 dependent. , 1999, Genes & development.
[25] H. Stein,et al. Oncogene-induced senescence as an initial barrier in lymphoma development , 2005, Nature.
[26] Albert J. Fornace,et al. Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity , 2002, Nature Genetics.
[27] G. Hannon,et al. MaRX: An Approach to Genetics in Mammalian Cells , 1999, Science.
[28] L Bibbs,et al. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. , 1994, Science.
[29] M. Fleming,et al. Endogenous oncogenic Nras mutation promotes aberrant GM-CSF signaling in granulocytic/monocytic precursors in a murine model of chronic myelomonocytic leukemia. , 2010, Blood.
[30] Peiqing Sun,et al. The pathways to tumor suppression via route p38. , 2007, Trends in biochemical sciences.
[31] Jiahuai Han,et al. The p38 Pathway Provides Negative Feedback for Ras Proliferative Signaling* , 2000, The Journal of Biological Chemistry.
[32] E. Wagner,et al. Distinct roles for JNK1 and JNK2 in regulating JNK activity and c-Jun-dependent cell proliferation. , 2004, Molecular cell.
[33] L. Donehower,et al. Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK–mediated activation of the p16Ink4a-p19Arf pathway , 2004, Nature Genetics.